Showing results (21-30 of 1,451) with videos related to
Sort By:
Pageof 146
International Clinical Psychopharmacology|March 17, 2001
Is amisulpride an 'atypical' atypical antipsychotic agent?Y LecrubierEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 15, 2000
Depressive illness and disabilityY LecrubierInternational Clinical Psychopharmacology|March 1, 1995
Clinical utility of venlafaxine in comparison with other antidepressantsY LecrubierEuropean Psychiatry : the Journal of the Association of European Psychiatrists|December 1, 2001
The influence of comorbidity on the prevalence of suicidal behaviourY LecrubierDrug Safety|April 1, 1994
Risk-benefit assessment of newer versus older monoamine oxidase (MAO) inhibitorsY LecrubierInternational Clinical Psychopharmacology|November 17, 1998
Is depression under-recognised and undertreated?Y LecrubierThe Journal of Clinical Psychiatry|July 4, 2001
Prescribing patterns for depression and anxiety worldwideY LecrubierThe Journal of Clinical Psychiatry|August 26, 1998
The impact of comorbidity on the treatment of panic disorderY LecrubierL'Encephale|April 1, 1997
[Schizophrenia, from classification to dimensions: value of longitudinal studies]Y LecrubierPageof 146